Kyla Hayford

1.8k total citations
51 papers, 982 citations indexed

About

Kyla Hayford is a scholar working on Epidemiology, Health and Immunology. According to data from OpenAlex, Kyla Hayford has authored 51 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 19 papers in Health and 9 papers in Immunology. Recurrent topics in Kyla Hayford's work include Vaccine Coverage and Hesitancy (19 papers), Virology and Viral Diseases (17 papers) and Respiratory viral infections research (14 papers). Kyla Hayford is often cited by papers focused on Vaccine Coverage and Hesitancy (19 papers), Virology and Viral Diseases (17 papers) and Respiratory viral infections research (14 papers). Kyla Hayford collaborates with scholars based in United States, Canada and Zambia. Kyla Hayford's co-authors include David P.L. Sachs, Darrell R. Schroeder, R. Douglas Hurt, Christi A. Patten, Elbert D. Glover, Teresa A. Rummans, Ivana T. Croghan, Kenneth P. Offord, William J. Moss and Orin S. Levine and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kyla Hayford

46 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyla Hayford United States	16	403	253	222	196	130	51	982
Fran Dong United States	26	324 0.8×	279 1.1×	113 0.5×	102 0.5×	98 0.8×	70	1.6k
Euzebiusz Jamrozik Australia	17	110 0.3×	322 1.3×	334 1.5×	95 0.5×	175 1.3×	63	966
Ekkehard Beck United States	17	273 0.7×	133 0.5×	115 0.5×	633 3.2×	32 0.2×	77	1.2k
Xiaohua Qi China	11	206 0.5×	138 0.5×	68 0.3×	67 0.3×	177 1.4×	23	682
Stephanie Konrad Canada	15	277 0.7×	82 0.3×	134 0.6×	53 0.3×	126 1.0×	28	981
Thomas Williams United Kingdom	15	359 0.9×	67 0.3×	218 1.0×	59 0.3×	82 0.6×	35	1.1k
Xiahong Zhao Singapore	14	521 1.3×	739 2.9×	407 1.8×	36 0.2×	88 0.7×	49	1.4k
William H. Foege United States	17	323 0.8×	186 0.7×	177 0.8×	66 0.3×	216 1.7×	71	1.0k
Melanie C. M. Murray Canada	18	253 0.6×	147 0.6×	522 2.4×	56 0.3×	80 0.6×	64	1.0k
Srinivas Rao Valluri United States	15	137 0.3×	454 1.8×	1.0k 4.5×	151 0.8×	60 0.5×	44	1.6k

Countries citing papers authored by Kyla Hayford

Since Specialization

Citations

This map shows the geographic impact of Kyla Hayford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyla Hayford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyla Hayford more than expected).

Fields of papers citing papers by Kyla Hayford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyla Hayford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyla Hayford. The network helps show where Kyla Hayford may publish in the future.

Co-authorship network of co-authors of Kyla Hayford

This figure shows the co-authorship network connecting the top 25 collaborators of Kyla Hayford. A scholar is included among the top collaborators of Kyla Hayford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyla Hayford. Kyla Hayford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perdrizet, Johnna, et al.. (2025). Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit. Infectious Diseases and Therapy. 14(3). 501–525. 2 indexed citations

Hayford, Kyla, et al.. (2025). Recommendations for pneumococcal vaccination of at-risk children: a global overview (2022–2024). Vaccine. 63. 127669–127669.

Rozenbaum, Mark H., Liping Huang, Johnna Perdrizet, et al.. (2024). Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants. Vaccine. 42(3). 573–582. 10 indexed citations

Cleary, David, James Campling, María Lahuerta, et al.. (2024). Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UK. Microbiology Spectrum. 12(8). e0022424–e0022424. 2 indexed citations

Grant, Lindsay R., Lalitagauri M. Deshpande, John H. Kimbrough, et al.. (2024). Characterization of Streptococcus pneumoniae isolates obtained from the middle ear fluid of US children, 2011–2021. Frontiers in Pediatrics. 12. 1383748–1383748. 3 indexed citations

Méroc, Estelle, Mark A. Fletcher, Germaine Hanquet, et al.. (2023). Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. Microorganisms. 11(7). 1816–1816. 9 indexed citations

Carcelen, Andrea C., Rupali J. Limaye, Simon Mutembo, et al.. (2023). Acceptability of serosurveys in southern Zambia: data collector and caregiver perspectives. SHILAP Revista de lepidopterología. 3(1). 3–3.

Perdrizet, Johnna, Kyla Hayford, Lindsay R. Grant, et al.. (2023). Historical Population-Level Impact of Infant 13-Valent Pneumococcal Conjugate Vaccine (PCV13) National Immunization Programs on Invasive Pneumococcal Disease in Australia, Canada, England and Wales, Israel, and the United States. Infectious Diseases and Therapy. 12(5). 1351–1364. 20 indexed citations

Wiens, Kirsten E., Bárbara Jaúregui, Benjamin F. Arnold, et al.. (2022). Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers. PLoS neglected tropical diseases. 16(10). e0010657–e0010657. 10 indexed citations

10.

Wasserman, Matt, et al.. (2021). Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infectious Diseases and Therapy. 10(4). 2701–2720. 28 indexed citations

11.

Prosperi, Christine, Kyla Hayford, Gururaj Deshpande, et al.. (2021). Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies. mSphere. 6(4). e0049021–e0049021. 13 indexed citations

12.

Bryant, Juliet E., Andrew S. Azman, Matthew J. Ferrari, et al.. (2020). Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward. Science Immunology. 5(47). 88 indexed citations

13.

Carcelen, Andrea C., Kyla Hayford, William J. Moss, et al.. (2020). How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia. PLoS ONE. 15(10). e0240734–e0240734. 6 indexed citations

14.

Gibson, Dustin G., et al.. (2019). Text Message Reminders and Unconditional Monetary Incentives to Improve Measles Vaccination in Western Kenya: Study Protocol for the Mobile and Scalable Innovations for Measles Immunization Randomized Controlled Trial. JMIR Research Protocols. 8(7). e13221–e13221. 7 indexed citations

15.

McDonald, Chloë R., Andrea L. Conroy, Michael Hawkes, et al.. (2016). Brain-derived Neurotrophic Factor Is Associated With Disease Severity and Clinical Outcome in Ugandan Children Admitted to Hospital With Severe Malaria. The Pediatric Infectious Disease Journal. 36(2). 146–150. 13 indexed citations

16.

Conroy, Andrea L., Michael Hawkes, Kyla Hayford, et al.. (2015). Prospective validation of pediatric disease severity scores to predict mortality in Ugandan children presenting with malaria and non-malaria febrile illness. Critical Care. 19(1). 47–47. 40 indexed citations

17.

Darling, Anne Marie, Chloë R. McDonald, Andrea L. Conroy, et al.. (2014). Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania. American Journal of Obstetrics and Gynecology. 211(5). 509.e1–509.e8. 35 indexed citations

18.

Hayford, Kyla, et al.. (2013). Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. BMC Public Health. 13(1). 1211–1211. 18 indexed citations

19.

Hayford, Kyla, et al.. (2013). Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. Journal of Virological Methods. 193(2). 512–518. 8 indexed citations

20.

Hayford, Kyla, Christi A. Patten, Teresa A. Rummans, et al.. (1999). Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism∗. The British Journal of Psychiatry. 174(2). 173–178. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact